SMCR8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.527000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.549400E-01
Normal-vs-Stage2
3.428800E-01
Normal-vs-Stage3
2.162200E-01
Normal-vs-Stage4
2.236000E-01
Stage1-vs-Stage2
3.378400E-01
Stage1-vs-Stage3
9.521900E-02
Stage1-vs-Stage4
4.227800E-01
Stage2-vs-Stage3
2.22679999999364E-05
Stage2-vs-Stage4
9.325600E-01
Stage3-vs-Stage4
1.873830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.573800E-01
Normal-vs-AfricanAmerican
2.078200E-01
Normal-vs-Asian
2.687400E-01
Caucasian-vs-AfricanAmerican
6.759200E-01
Caucasian-vs-Asian
1.428580E-01
AfricanAmerican-vs-Asian
1.011840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.276800E-01
Normal-vs-Female
3.891200E-01
Male-vs-Female
1.002030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.554400E-01
Normal-vs-Age(41-60Yrs)
3.995400E-01
Normal-vs-Age(61-80Yrs)
3.315400E-01
Normal-vs-Age(81-100Yrs)
2.978800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.366600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.476600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.015200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.122000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.720100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.465000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.073600E-01
Normal-vs-Daily Drinker
2.734800E-01
Normal-vs-Weekly Drinker
3.355400E-01
Normal-vs-Occasional Drinker
3.470200E-01
Normal-vs-Social Drinker
1.360380E-01
Non Drinker-vs-Daily Drinker
4.416200E-01
Non Drinker-vs-Weekly Drinker
6.735600E-01
Non Drinker-vs-Occasional Drinker
4.816000E-01
Non Drinker-vs-Social Drinker
1.262160E-01
Daily Drinker-vs-Weekly Drinker
2.272200E-01
Daily Drinker-vs-Occasional Drinker
1.065560E-01
Daily Drinker-vs-Social Drinker
4.959800E-02
Weekly Drinker-vs-Occasional Drinker
8.348600E-01
Weekly Drinker-vs-Social Drinker
3.301600E-01
Occasional Drinker-vs-Social Drinker
3.558200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.027600E-01
Normal-vs-Grade 2
9.918200E-01
Normal-vs-Grade 3
9.830600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.212230E-01
Grade 1-vs-Grade 3
2.101200E-01
Grade 1-vs-Grade 4
7.027600E-01
Grade 2-vs-Grade 3
6.876200E-01
Grade 2-vs-Grade 4
9.918200E-01
Grade 3-vs-Grade 4
9.830600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.044400E-01
Normal-vs-NonDiabetic
3.498600E-01
Diabetic-vs-NonDiabetic
1.826170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.895600E-01
Normal-vs-NoPancreatitis
3.378000E-01
Pancreatitis-vs-NoPancreatitis
3.628600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.499000E-01
Normal-vs-N1
3.465000E-01
N0-vs-N1
9.582400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.023200E-01
Normal-vs-TP53-NonMutant
4.625000E-01
TP53-Mutant-vs-TP53-NonMutant
2.878300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
